Authors :
Athira Ajith; Dr. Usha Subbiah
Volume/Issue :
Volume 10 - 2025, Issue 10 - October
Google Scholar :
https://tinyurl.com/24wjh3fj
Scribd :
https://tinyurl.com/3d2e55wm
DOI :
https://doi.org/10.38124/ijisrt/25oct623
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Note : Google Scholar may take 30 to 40 days to display the article.
Abstract :
Background:
Plant-derived compounds play a vital role in the development of several therapeutic agents. Phyllanthus emblica,
Indian gooseberry has both dietary and medicinal uses. Its fruit is health beneficial, and the seeds are eliminated during
consumption which may have biological activity hence the seed of P. emblica has to be investigated. Our study aims to
evaluate the antioxidant, antibacterial activity, in vitro cytotoxic potential and to determine the presence of various
bioactive compounds of P. emblica seed extract. The ethanolic P. emblica seed extract was subjected to phytochemical
screening and antibacterial activity was evaluated using the well diffusion method against Streptococcus mutans and
Enterococcus faecalis. Antioxidant ability was determined by DPPH, ABTS and phosphomolybdenum reduction assay.
Further, Gas chromatography-mass spectrometry (GC-MS) was used for the identification of bioactive compounds.
Results:
The phytochemical screening identified the presence of secondary metabolites such as terpenoids, phytosterols,
phenols, flavonoids, tannins, glycosides, carbohydrates, saponins, and quinines in P. emblica seed extract. The total tannin
and flavonoid contents were 514.24 mg TAE/g and 861.9 mg QE/g respectively. The seed extract exhibited antibacterial
activity against S. mutans and E. faecalis. The ethanolic seed extract showed high scavenging activity in DPPH (96.38%),
ABTS (98.88%) assay and had a potent reductive ability (81.92%) in phosphomolybdate assay. The MTT assay revealed
the extract exhibited maximum cytotoxicity against SCC25 cells at a concentration of 200 μg/ml. The GC-MS analysis of
the P. emblica seed extract showed the presence of 17 bioactive compounds and the major compounds were
cyclotrisiloxane, hexamethyl, di-n-octyl phthalate, 1,2-dihydro-1,4-dimethoxy-2-oxoquinazoline, calycotomine, methyl,
phenol, 2,4-bis (1,1-dimethyl ethyl) and 1-dodecanol, 3,7,11-trimethyl. Hence, the presence of these compounds in seed
extract may be responsible for therapeutic intervention.
Conclusions:
The study analysed the biological activity of the seed, and the identified bioactive phytochemicals could be selected in
the pharmaceutical industry for drug discovery.
Keywords :
Phyllanthus emblica, Antioxidant, Antibacterial, Cytotoxicity, GC-MS, Bioactive Compounds.
References :
- X. Liu et al., “Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities,” Food Chem., vol. 109, no. 4, pp. 909–915, 2008. https://doi.org/10.1016/j.foodchem.2008.01.071
- S. Sriwatcharakul, “Evaluation of bioactivities of Phyllanthus emblica seed,” Energy Reports, vol. 6, pp. 442–447, 2020. https://doi.org/10.1016/j.egyr.2019.08.088
- P. Mishra, S. Mishra, and C. L. Mahanta, “Effect of maltodextrin concentration and inlet temperature during spray drying on physicochemical and antioxidant properties of amla (Emblica officinalis) juice powder,” Food Bioprod. Process., vol. 92, no. 3, pp. 252–258, 2014. https://doi.org/10.1016/j.fbp.2013.08.003
- I. Ahmad, Z. Mehmood, and F. Mohammad, “Screening of some Indian medicinal plants for their antimicrobial properties,” J. Ethnopharmacol., vol. 62, no. 2, pp. 183–193, 1998. https://doi.org/10.1016/S0378-8741(98)00055-5
- U. R. Chatterjee, S. S. Bandyopadhyay, D. Ghosh, P. K. Ghosal, and B. Ray, “In vitro anti-oxidant activity, fluorescence quenching study and structural features of carbohydrate polymers from Phyllanthus emblica,” Int. J. Biol. Macromol., vol. 49, no. 4, pp. 637–642, 2011. doi: 10.1016/j.ijbiomac.2011.06.024.
- M. Sumitra, P. Manikandan, V. S. Gayathri, P. Mahendran, and L. Suguna, “Emblica officinalis exerts wound healing action through up‐regulation of collagen and extracellular signal‐regulated kinases (ERK1/2),” Wound Repair Regen., vol. 17, no. 1, pp. 99–107, 2009. https://doi.org/10.1111/j.1524-475X.2008.00446.x
- M. Golechha, J. Bhatia, S. Ojha, and D. S. Arya, “Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention,” Pharm. Biol., vol. 49, no. 11, pp. 1128–1136, 2011. https://doi.org/10.3109/13880209.2011.571264
- R. Mythilypriya, P. Shanthi, and P. Sachdanandam, “Analgesic, antipyretic and Ulcerogenic properties of an indigenous formulation–Kalpaamruthaa,” Phyther. Res. An Int. J. Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv., vol. 21, no. 6, pp. 574–578, 2007. doi: 10.1002/ptr.2116.
- J. B. Perianayagam, S. K. Sharma, A. Joseph, and A. J. M. Christina, “Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn,” J. Ethnopharmacol., vol. 95, no. 1, pp. 83–85, 2004. doi: 10.1016/j.jep.2004.06.020
- M. S. Baliga, S. Meera, B. Mathai, M. P. Rai, V. Pawar, and P. L. Palatty, “Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review,” Chin. J. Integr. Med., vol. 18, pp. 946–954, 2012. doi: 10.1007/s11655-012-1299-x.
- R. K. Gulati, S. Agarwal, and S. S. Agrawal, “Hepatoprotective studies on Phyllanthus emblica Linn. and quercetin.,” Indian J. Exp. Biol., vol. 33, no. 4, pp. 261–268, 1995. https://doi.org/10.1016/B978-0-12-814466-4.00016-1
- K. Suresh and D. M. Vasudevan, “Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator,” J. Ethnopharmacol., vol. 44, no. 1, pp. 55–60, 1994. doi: 10.1016/0378-8741(94)90099-x.
- K. Sairam, C. V Rao, M. D. Babu, K. V. Kumar, V. K. Agrawal, and R. K. Goel, “Antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study,” J. Ethnopharmacol., vol. 82, no. 1, pp. 1–9, 2002. https://doi.org/10.1016/S0378-8741(02)00041-7
- M. Vasudevan and M. Parle, “Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): An Ayurvedic preparation,” Physiol. Behav., vol. 91, no. 1, pp. 46–54, 2007. doi: 10.1016/j.physbeh.2007.01.016.
- 2006. N. Raaman, Phytochemical techniques. New India Publishing, No Title.
- E. Attard, “A rapid microtitre plate Folin-Ciocalteu method for the assessment of polyphenols,” Open Life Sci., vol. 8, no. 1, pp. 48–53, 2013. https://doi.org/10.2478/s11535-012-0107-3
- X. Liu, M. Dong, X. Chen, M. Jiang, X. Lv, and G. Yan, “Antioxidant activity and phenolics of an endophytic Xylaria sp. from Ginkgo biloba,” Food Chem., vol. 105, no. 2, pp. 548–554, 2007. https://doi.org/10.1016/j.foodchem.2007.04.008
- N. Saeed, M. R. Khan, and M. Shabbir, “Antioxidant activity, total phenolic and total flavonoid contents of whole plant extracts Torilis leptophylla L,” BMC Complement. Altern. Med., vol. 12, pp. 1–12, 2012. https://doi.org/10.1186/1472-6882-12-221
- Z. Cheng, J. Moore, and L. Yu, “High-throughput relative DPPH radical scavenging capacity assay,” J. Agric. Food Chem., vol. 54, no. 20, pp. 7429–7436, 2006. https://doi.org/10.1021/jf0611668
- R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radic. Biol. Med., vol. 26, no. 9–10, pp. 1231–1237, 1999. https://doi.org/10.1016/S0891-5849(98)00315-3
- P. Prieto, M. Pineda, and M. Aguilar, “Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E,” Anal. Biochem., vol. 269, no. 2, pp. 337–341, 1999. https://doi.org/10.1006/abio.1999.4019
- I. Kubo, H. Muroi, and M. Himejima, “Antimicrobial activity of green tea flavor components and their combination effects,” J. Agric. Food Chem., vol. 40, no. 2, pp. 245–248, 1992. https://doi.org/10.1021/jf00014a015
- S. Gheda, A. Abdel Hamid, and T. M. Mohamed, “Antibacterial and antioxidant activities of Phlorotannins extracted from Sargassum linifolium brown alga,” Delta J. Sci., vol. 41, no. 1, pp. 30–38, 2019. https://doi.org/10.3390/app13084711
- N. M. Adjémé, M. Kalo, and Y. Soro, “Phyto chemical study and antioxidant activities of leaves of Euphorbia heterophylla L.(Euphorbiaceae),” J. Mater. Environ. Sci., 14 (4), 462, vol. 474, 2023.
- H. S. Ouandaogo, S. Diallo, E. Odari, and J. Kinyua, “Phytochemical Screening and GC-MS Analysis of Methanolic and Aqueous Extracts of Ocimum kilimandscharicum Leaves,” ACS omega, vol. 8, no. 50, pp. 47560–47572, 2023. https://doi.org/10.1021/acsomega.3c05554
- L. Zhao et al., “A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs,” Bioorg. Med. Chem., vol. 27, no. 5, pp. 677–685, 2019. doi: 10.1016/j.bmc.2019.01.027.
- K. Zhao et al., “LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo,” Gene, vol. 642, pp. 533–541, 2018. doi: 10.1016/j.gene.2017.11.065.
- K. Patel, V. Kumar, M. Rahman, A. Verma, and D. K. Patel, “New insights into the medicinal importance, physiological functions and bioanalytical aspects of an important bioactive compound of foods ‘Hyperin’: Health benefits of the past, the present, the future,” Beni-Suef Univ. J. Basic Appl. Sci., vol. 7, no. 1, pp. 31–42, 2018. https://doi.org/10.1016/j.bjbas.2017.05.009
- D. Sumalatha, “Antioxidant and antitumor activity of Phyllanthus emblica in colon cancer cell lines.,” International Journal of Current Microbiology and Applied Sciences 2(5), 2319-7706, 2013.
- J. Cao, Y. Zhang, W. Chen, and X. Zhao, “The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake,” Br. J. Nutr., vol. 103, no. 2, pp. 249–255, 2010. doi: 10.1017/S000711450999170X.
- J. Jia et al., “Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms,” Chinese Herb. Med., vol. 13, no. 1, pp. 49–63, 2021. doi: 10.1016/j.chmed.2020.09.002
- N. U. Olivia, U. C. Goodness, and O. M. Obinna, “Phytochemical profiling and GC-MS analysis of aqueous methanol fraction of Hibiscus asper leaves,” Futur. J. Pharm. Sci., vol. 7, pp. 1–5, 2021. https://doi.org/10.1186/s43094-021-00208-4
- M. Umamaheswari and T. K. Chatterjee, “In vitro antioxidant activities of the fractions of Coccinia grandis L. leaf extract,” African J. Tradit. Complement. Altern. Med., vol. 5, no. 1, pp. 61–73, 2008. DOI:10.4314/ajtcam.v5i1.31258
- X. P. Nunes et al., Biological oxidations and antioxidant activity of natural products. INTECH Open Access Publisher New York, 2012. DOI: 10.5772/26956
- R. A. Khan, M. R. Khan, S. Sahreen, and M. Ahmed, “Assessment of flavonoids contents and in vitro antioxidant activity of Launaea procumbens,” Chem. Cent. J., vol. 6, no. 1, pp. 1–11, 2012. https://doi.org/10.1186/1752-153X-6-43
- W. Luo, M. Zhao, B. Yang, J. Ren, G. Shen, and G. Rao, “Antioxidant and antiproliferative capacities of phenolics purified from Phyllanthus emblica L. fruit,” Food Chem., vol. 126, no. 1, pp. 277–282, 2011. https://doi.org/10.1016/j.foodchem.2010.11.018
Background:
Plant-derived compounds play a vital role in the development of several therapeutic agents. Phyllanthus emblica,
Indian gooseberry has both dietary and medicinal uses. Its fruit is health beneficial, and the seeds are eliminated during
consumption which may have biological activity hence the seed of P. emblica has to be investigated. Our study aims to
evaluate the antioxidant, antibacterial activity, in vitro cytotoxic potential and to determine the presence of various
bioactive compounds of P. emblica seed extract. The ethanolic P. emblica seed extract was subjected to phytochemical
screening and antibacterial activity was evaluated using the well diffusion method against Streptococcus mutans and
Enterococcus faecalis. Antioxidant ability was determined by DPPH, ABTS and phosphomolybdenum reduction assay.
Further, Gas chromatography-mass spectrometry (GC-MS) was used for the identification of bioactive compounds.
Results:
The phytochemical screening identified the presence of secondary metabolites such as terpenoids, phytosterols,
phenols, flavonoids, tannins, glycosides, carbohydrates, saponins, and quinines in P. emblica seed extract. The total tannin
and flavonoid contents were 514.24 mg TAE/g and 861.9 mg QE/g respectively. The seed extract exhibited antibacterial
activity against S. mutans and E. faecalis. The ethanolic seed extract showed high scavenging activity in DPPH (96.38%),
ABTS (98.88%) assay and had a potent reductive ability (81.92%) in phosphomolybdate assay. The MTT assay revealed
the extract exhibited maximum cytotoxicity against SCC25 cells at a concentration of 200 μg/ml. The GC-MS analysis of
the P. emblica seed extract showed the presence of 17 bioactive compounds and the major compounds were
cyclotrisiloxane, hexamethyl, di-n-octyl phthalate, 1,2-dihydro-1,4-dimethoxy-2-oxoquinazoline, calycotomine, methyl,
phenol, 2,4-bis (1,1-dimethyl ethyl) and 1-dodecanol, 3,7,11-trimethyl. Hence, the presence of these compounds in seed
extract may be responsible for therapeutic intervention.
Conclusions:
The study analysed the biological activity of the seed, and the identified bioactive phytochemicals could be selected in
the pharmaceutical industry for drug discovery.
Keywords :
Phyllanthus emblica, Antioxidant, Antibacterial, Cytotoxicity, GC-MS, Bioactive Compounds.